KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Progyny (PGNY) Revenue (2018 - 2025)

Progyny (PGNY) has disclosed Revenue for 8 consecutive years, with $318.4 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 6.69% to $318.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 10.4% year-over-year, with the annual reading at $1.3 billion for FY2025, 10.4% up from the prior year.
  • Revenue for Q4 2025 was $318.4 million at Progyny, up from $313.3 million in the prior quarter.
  • The five-year high for Revenue was $332.9 million in Q2 2025, with the low at $122.1 million in Q1 2021.
  • Average Revenue over 5 years is $241.6 million, with a median of $274.0 million recorded in 2023.
  • The sharpest move saw Revenue soared 99.13% in 2021, then rose 2.04% in 2024.
  • Over 5 years, Revenue stood at $127.6 million in 2021, then surged by 68.03% to $214.3 million in 2022, then rose by 25.95% to $269.9 million in 2023, then grew by 10.55% to $298.4 million in 2024, then rose by 6.69% to $318.4 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $318.4 million, $313.3 million, and $332.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.